Form 4: ANI Pharmaceuticals Executive Meredith Cook Sells 250 Shares
SEC Form 4
Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 250 shares of common stock on April 12, 2024, at a price of $67.79 per share.
Summary
- On April 12, 2024, Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 250 shares of common stock.
- The sale was executed at a price of $67.79 per share.
- Following the transaction, Meredith Cook directly owns 59,731 shares of ANI Pharmaceuticals.
- The sale was conducted under a Rule 10b5-1 trading plan adopted on August 11, 2023.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard Form 4 filing for an insider stock sale under a pre-existing 10b5-1 plan.
Industry Context
This is a routine disclosure of an insider transaction. Insider sales can sometimes be interpreted negatively by the market, but the existence of a 10b5-1 plan suggests the sale was pre-planned and not based on current inside information.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, although the pre-planned nature of the sale mitigates this.
Key Dates
| Date | Description |
|---|---|
| 08/11/2023 | Date of adoption of Rule 10b5-1 trading plan |
| 04/12/2024 | Date of transaction (stock sale) |
| 04/15/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.